Month: January 2023

Press contact:Antara NandyTel: + 91 9674515119 Email: antara.nandy@capgemini.com Enabling cost reductions will be key for retailers to attract today’s frugal consumer New report finds most consumers (61%) are concerned about their financial situation and 69% are cutting back on non-essential expenses Paris, January 09, 2023 – 61% of consumers are concerned about their financial situations, with Millennials1 (66%) and Gen X2 (64%) being the most worried, and Boomers3 (55%) the least. To navigate these pressures, almost half (44%) of consumers say they are reducing their overall spending; an increase from 33% of respondents who said the same in November 2020. This is according to the second edition of Capgemini Research Institute’s annual consumer trends report, ‘What Matters to Today’s Consumer,’ which reveals the impact of an increased...

NEOLIFE Calendrier de communication financière 2023 (Ce calendrier est indicatif et peut être soumis à modification)31 janvier 2023                Chiffre d’affaires 202231 mars 2023                        Publication des résultats 2022Juin 2023                        Assemblée générale annuelle31 juillet 2023                        Chiffre d’affaires du 1er semestre 202330 septembre 2023                Publication des résultats semestriels 2023CONTACTNEOLIFE®investors@neolife.frAttachmentCP NEOLIFE 09 JANVIER 2023

Restructuring was successfully implemented through a pre-arranged Chapter 11 process in U.S. Bankruptcy Court Restructuring significantly deleveraged Altera’s balance sheet by equitizing more than $1 billion in junior debt obligations and facilitated a long term, sustainable positive liquidity outlook Raised $94mm in capital through an equity rights offering, which will be used to provide liquidity and repay certain credit facilities in full Altera and Equinor signed a bareboat charter related to the Petrojarl Knarr FPSO, which will generate significant future cash flowsWESTHILL, United Kingdom, Jan. 09, 2023 (GLOBE NEWSWIRE) — Altera Infrastructure L.P. and certain of its subsidiaries (“Altera”), one of the world’s leading suppliers of infrastructure assets to the offshore energy industry, announced today that it has emerged...

In December 2022, the Estonian FSA presented Bigbank AS with the outcome of the annual Supervisory Review and Evaluation Process (SREP) capital adequacy calculation. As an outcome of the evaluation the FSA decided to establish new Pillar 2 capital requirement and guidance for Bigbank AS. According to the decision of the FSA, an additional requirement for own funds (P2R) in the amount of 4.49% from the total risk exposure amount (TREA) applies to Bigbank AS on concolidated bases, of which at least 3.37% must be covered with Core Tier 1 own funds and at least 2.52% with Tier 1 capital. The 4.49% Pillar 2 capital requirement is the same ratio what was applicable to Bigbank AS as well before the decision. The total SREP capital requirement for Bigbank AS amounts thus to 12.49%. This is the sum of the total Pillar 1 requirement of 8% and the...

Amsterdam, 9 January 2022 — AMG Advanced Metallurgical Group N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) announces the Management Board has approved to build a Vanadium Electrolyte plant at its subsidiary, AMG Titanium, in Nuremberg, Germany. The target capacity is 6,000 m³ vanadium electrolyte. Basic engineering for the plant was completed in November, with production expected to start at the end of 2023. Given the outlook for the vanadium redox flow battery market, AMG Titanium’s technological expertise in producing highly purified Vanadium products, and AMG LIVA’s raw material requirements for the battery Hybrid Energy Storage Systems (“HESS”), this expansion is a vital strategic investment for AMG and will strengthen AMG’s strategy to enable energy efficiency and CO2 reduction for its customers in industrial operations. About AMG AMG...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, and Rockville, MD, USA, January 9, 2023 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for vamorolone for the treatment of Duchenne muscular dystrophy (DMD) for filing. The FDA has set October 26, 2023, as the Prescription Drug User Fee Act (PDUFA) target action date. The PDUFA date is the target date for the FDA to complete its review of the NDA. Furthermore, the FDA stated that it does not currently plan to hold an advisory committee meeting to discuss the application. Subject to approval, Santhera plans to launch vamorolone in the U.S. in Q4-2023. “We are delighted that the FDA has accepted Santhera’s vamorolone NDA for filing. We believe this product...

Press Release VELIZY-VILLACOUBLAY, France — January 9, 2023 Dassault Systèmes Governance Plan Announced in 2022 Now Effective Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announces that the governance organization carefully crafted over years and aligned with the company long term strategy, as communicated on April 27, 2022, is effective today:Charles Edelstenne, Founder, is handing over his position as Chairman of the Board of Directors, remains Director and becomes Honorary Chairman. Bernard Charlès, Vice Chairman of the Board of Directors and Chief Executive Officer, becomes Chairman and Chief Executive Officer. Pascal Daloz, Chief Operating Officer, is also appointed Deputy Chief Executive Officer. Daloz is member of the Board of Directors.Laurence Daures (formerly Lescourret), an independent Director and Chair of...